Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

35.56
+0.03000.08%
Pre-market: 35.980.4200+1.18%08:25 EDT
Volume:693.97K
Turnover:24.88M
Market Cap:6.56B
PE:-19.97
High:36.80
Open:35.72
Low:35.49
Close:35.53
52wk High:59.62
52wk Low:27.34
Shares:184.57M
Float Shares:81.38M
Volume Ratio:0.77
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7807
EPS(LYR):-0.9681
ROE:-29.65%
ROA:-7.81%
PB:6.34
PE(LYR):-36.73

Loading ...

U.S. RESEARCH ROUNDUP-Amgen, Figma, Nordson

Reuters
·
5 hours ago

Legend Biotech Corp : JP Morgan Raises Target Price to $78.00 From $77.00

THOMSON REUTERS
·
9 hours ago

Legend Biotech Corp - Carlos Santos Assumes CFO Role From Jessie Yeung

THOMSON REUTERS
·
Aug 18

Press Release: Legend Biotech Appoints Carlos Santos as Chief Financial Officer

Dow Jones
·
Aug 18

Legend Biotech’s Earnings Call: Growth and Success

TIPRANKS
·
Aug 13

Legend Biotech Is Maintained at Outperform by RBC Capital

Dow Jones
·
Aug 12

Legend Biotech price target raised to $77 from $75 at RBC Capital

TIPRANKS
·
Aug 12

RBC Capital Adjusts Price Target on Legend Biotech to $77 From $75, Maintains Outperform Rating

MT Newswires Live
·
Aug 12

Legend Biotech’s Strategic Growth and Record Sales Drive Buy Rating

TIPRANKS
·
Aug 12

Strong Buy Rating for Legend Biotech Driven by CARVYKTI’s Market Success and Strategic Expansions

TIPRANKS
·
Aug 12

Barclays Keeps Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Legend Biotech’s Hold Rating: Balancing Strong Revenue Growth with Strategic Uncertainties

TIPRANKS
·
Aug 12

Sector Update: Health Care Stocks Rise Premarket Monday

MT Newswires Live
·
Aug 11

Legend Biotech Reports Q2 2025 Results: Adjusted Net Income of $10.1M, Collaboration Revenue Soars to $219.7M

Reuters
·
Aug 11

Legend Biotech Q2 EPS $(0.34) Misses $(0.14) Estimate, Sales $255.058M Beat $234.236M Estimate

Benzinga
·
Aug 11

Legend Biotech Corporation Q2 Net Income USD -125.38 Million

THOMSON REUTERS
·
Aug 11

Legend Biotech Corporation Q2 EPS USD -0.34

THOMSON REUTERS
·
Aug 11

Legend Biotech Corporation Q2 Adjusted EPS USD 0.03

THOMSON REUTERS
·
Aug 11

Legend Biotech Corp - FDA Removes Rems for Bcma & Car T Cell Therapies Including Carvykti

THOMSON REUTERS
·
Aug 11

Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights

GlobeNewswire
·
Aug 11